New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment

Marc Ladanyi, Marjorie G. Zauderer, Lee M. Krug, Tatsuo Ito, Robert McMillan, Matthew Bott, Filippo Giancotti

Research output: Contribution to journalArticle

55 Scopus citations

Fingerprint Dive into the research topics of 'New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment'. Together they form a unique fingerprint.

Medicine & Life Sciences